Percutaneous Closure of Mitral Paravalvular Leak

537-540

Authors

  • Gerardo Nau Service of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular de Buenos Aires (ICBA). Buenos Aires, Argentina
  • Mariano Albertal Service of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular de Buenos Aires (ICBA). Buenos Aires, Argentina
  • Mariano Vrancic Service of Cardiovascular Surgery, Instituto Cardiovascular de Buenos Aires (ICBA). Buenos Aires, Argentina
  • Ricardo Ronderos Service of Diagnostic Imaging, Instituto Cardiovascular de Buenos Aires (ICBA). Buenos Aires, Argentina
  • Gustavo Sánchez Service of Diagnostic Imaging, Instituto Cardiovascular de Buenos Aires (ICBA). Buenos Aires, Argentina
  • Daniel Navia Service of Cardiovascular Surgery, Instituto Cardiovascular de Buenos Aires (ICBA). Buenos Aires, Argentina
  • Sebastián Peralta Service of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular de Buenos Aires (ICBA). Buenos Aires, Argentina
  • Jorge Belardi Service of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular de Buenos Aires (ICBA). Buenos Aires, Argentina
  • Fernando Cura Service of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular de Buenos Aires (ICBA). Buenos Aires, Argentina

DOI:

https://doi.org/10.7775/rac.v79i6.1973

Keywords:

Heart Valve Prosthesis, Prosthesis Failure, Percutaneous Closure

Abstract

The development of paravalvular leak (PVL) after mitral valve replacement is a rare event but of high symptomatic incidence.The surgical repair of this condition has high morbidity and mortality; for this reason, several percutaneous techniques have been attempted with a successful rate that varies between 60% and 90%. In this presentation is described the case of a young female patient, with multiple prior mitral valve surgeries, symptomatic because of limiting dyspnea and hemolytic anemia. The PVL was closed using a specially designed Amplatzer III device under three-dimensional echocardiographic images. After 3 months of follow up, the PVL remains totally excluded and the patient is asymptomatic.

Published

2025-10-28

Issue

Section

SCIENTIFIC LETTERS

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 > >>